FBLG Receives Patent Notice
FibroBiologics Receives U.S. Patent And Trademark Office Notice Of Allowance For Patented Application Entitled Therapeutic Use Of Fibroblasts In Wound Healing
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results.
FBLG Receives US Patent
FBLG - FibroBiologics Receives Notice of Allowance for U.S. Patent Covering Topical Fibroblast Spheroid Therapy for Wound HealingAllowed claims directly support the Company's ongoing Phase 1/2 clinical trial of CYWC628 in patients with diabetic foot ulcers